Login
$BCLI
$1.05 -$0.02 (1.87%) Close

$BCLI SEC Filings

Filed On Filing
14 Aug 2026 10-Q
14 Aug 2026 8-K: Results of Operations and Financial Condition
30 Jul 2026 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
28 Jul 2026 Form 4: Frenkel Jacob A, Director

Received 100,000 shares as a grant or award

28 Jul 2026 Form 4: Pitts Peter Joe, Director

Granted 900,000 Stock Option (Right to Buy)

03 Jun 2026 Form 3: Pitts Peter Joe, Director
02 Jun 2026 EFFECT
01 Jun 2026 CORRESP
29 May 2026 Form 4: Lebovits Chaim, President & CEO

Received 1,800,000 shares as a grant or award

29 May 2026 Form 4: Yablonka Uri, Director

Received 150,000 shares as a grant or award

29 May 2026 Form 4: Patlis Alla, See Remarks

Received 100,000 shares as a grant or award

29 May 2026 Form 4: Frenkel Jacob A, Director

Received 200,000 shares as a grant or award

29 May 2026 Form 4: Arbel Irit, Director

Received 120,000 shares as a grant or award

28 May 2026 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
27 May 2026 UPLOAD
21 May 2026 FORM S-8
21 May 2026 S-1
20 May 2026 Form 4: Bairu Menghisteab, Director

Granted 150,000 Stock Option (Right to Buy) ($105K)

20 May 2026 Form 4: Polverino Anthony J., Director

Granted 150,000 Stock Option (Right to Buy) ($105K)

20 May 2026 Form 4: Hartounian Hartoun, Director

Granted 225,000 Stock Option (Right to Buy) ($158K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support